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Introduction
Autism Spectrum Disorder (ASD) is a neurological impairment 
where the child has a problem interacting with others, has trou-
ble communicating verbally and non-verbally, and exhibits odd 
behaviors such as repeating certain actions over and over again 
and acting out if something does not go according to routine 
(Block et. al., 2006).  A child with ASD will have trouble making 
eye contact with those interacting with him and will be unable 
to understand what others are thinking or feeling because they 
have trouble picking up on social cues (“What is Autism”, 2009) 
ASD is predicted to occur in three to six children for every 
1000 who are born.  It is 5 times more likely for a male to get 
autism than a female, however if a female does have autism her 
symptoms are more severe.  Autism Spectrum Disorder is cat-
egorized as a pervasive developmental disorder because there 
are many different symptoms and behaviors for people with 
autism.  Someone who has severe symptoms of autism can be 
placed on one end of the spectrum, while someone with a mild-
er case can be on the opposite end of the spectrum.  Different 
forms of ASD include Rett’s disorder, childhood disintegrative 
disorder, and Asperger’s syndrome. (Block et. al., 2006).
Methods
The information that was collected for this research paper was 
obtained through Proquest, Ebsco, Pubmed, and the NIH web-
site.  These resources were provided from the Touro College 
Library.  Key words included autism, ASD, vaccinations, genetics, 
and environmental factors.
Discussion: Diagnosing Autism
There is no specific test done to determine if a child has ASD 
because the symptoms and behaviors are so broad and can vary 
significantly between each child.  Although children can start 
showing symptoms between 15-18 months of age, the aver-
age age of diagnosing is four to five years old.  Diagnosis for 
ASD should be done by gathering developmental history of 
the child, and by direct observation of the behaviors of the 
child.  There should be a team of different professionals who 
can assess symptoms and behaviors of the child.  The team 
should include a pediatrician, a child psychiatrist, and a speech 
and language therapist, and a child psychologist.  Behavior of 
the child should be observed in different settings such as in 
his home and in his school.  The team should be looking for 
different behaviors that are prevalent in children with ASD. 
Prognosis of each case is done on an individual basis because 
the behaviors of the child can vary greatly, and the behaviors 
can even change over time.  Some people with autism can lead 
productive lives, such as those with high functioning Asperger’s 
syndrome, while others will need assistance all through their 
lives (Yates et. al., 2013). 
MMR Vaccine and Autism
There has been much talk over the years about a possible 
link between the Mumps, Measles and Rubella (MMR) vaccine 
and autism.  The supposed link caused major panic because 
vaccines are needed to prevent, in this case, mumps measles 
and rubella from spreading.  Vaccines were a vital discovery 
which prevented many infectious diseases from recurring over 
and over again around the world.  
The link between the vaccine and autism was introduced by 
Andrew Wakefield in 1998 (cited in Richards, 2011), when 
he conducted an experiment using twelve children to prove 
the link.  It came out later, while his experiment was under 
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investigation, that he altered many of the details of the chil-
dren’s previous symptoms and behaviors. Therefore his study 
had no scientific basis to prove a link.  Many studies have been 
done since then to disprove the supposed link between the 
MMR vaccine and autism (Richards, 2011).
One reason why people may think there is a link between 
the MMR vaccine and ASD is because children start show-
ing signs of autism right around the time that they get the 
vaccine.  The explanation for this is that the vaccine is given 
to children only after they are a year old, which is when 
children start showing symptoms and unusual behavior.  Just 
because these events happen around the same time does not 
mean that there is any basis for a connection.  Many studies 
were done to try to prove a link between the vaccine and 
autism but none of them have been successful (‘Autism and 
the MMR Vaccine’, 2001).
Investigations done to disprove the link
In 2000, the Institute of Medicine at the National Academy of 
Science, under the request of the CDC and NIH conducted 
a review of all the evidence linking the MMR vaccine to ASD. 
They took under consideration all the studies and conclud-
ed that the evidence did not support an association between 
the vaccine and autism.  Furthermore in 2000, the American 
Academy of Pediatrics held a conference to review the infor-
mation and found no evidence in support of a linkage (‘Autism 
and the MMR Vaccine’, 2001).  
In 1999, Taylor and colleagues published a study to determine 
a connection between the MMR vaccine and autism (‘Autism 
and the MMR Vaccine’, 2001). He took all the known cases of 
ASD in children living in certain districts in London who were 
born in 1979 or later and matched the ASD patients with an 
independent registry of vaccinations.  His results were: 1. the 
number of ASD cases had increased steadily since 1979 but 
there was no steep incline in cases after doctors started using 
the MMR vaccine.  2. Children showed symptoms and were 
diagnosed with ASD all at around the same age, regardless if 
they got the vaccine before or after 18 months of age.  This 
is important because if the children were vaccinated they 
would have shown signs of ASD earlier than those children 
who were not vaccinated.  3.  Lastly, by age two the number 
of children who got the vaccine and showed signs for ASD 
was almost the same amount as children who got the vaccine 
but did not show any symptoms.  If there was a connection 
between the MMR vaccine and autism more children should 
have shown symptoms for ASD (NICHD, 2001).  Although the 
MMR vaccine was a popular theory concerning the causes of 
autism, many later studies failed to show a connection.  This 
still remains controversial and continues to be studied. 
Genetic factors that may cause ASD
possible genetic mutations that cause autism
Another possible cause of autism is genetic mutations in the 
genome of the affected person.  Mutations in genes that are 
responsible for encoding proteins which are involved in molec-
ular machinery regulating synaptic protein synthesis is strongly 
connected to autism.  Autism possibly can be caused due to 
mutations known as Fragile X Syndrome and tuberous sclerosis 
(TS).  Both of these syndromes are caused by abnormal mRNA 
translation, resulting in excess protein synthesis. 
Fragile X Syndrome (FXS) is caused by an unstable expansion of 
the CGG repeat in the FMR1 gene.  The prevalence of autism in 
the FXS mutation is 30%.  This gene mutation causes abnormal 
methylation production, FMR1 transcription silencing, and de-
creased FMRP protein levels in the brain.  ASD in FXS is mainly 
characterized by deficits in peer interaction.  Tuberous sclerosis 
is an autosomal dominant disease that is caused by a mutation on 
either the TSC1 or TSC2 gene.  Clinical manifestations of tuberous 
sclerosis included epilepsy, learning difficulties, and behavioral prob-
lems.  There are a variety of mutations that cause tuberous sclero-
sis including nonsense, missense, insertion, and deletion mutations. 
Autism is significantly more frequent among TS patients than in the 
general population.  Because there is a large phenotypic variability 
in FXS and TS with patients who have autism, research is being 
done to make a clear correlation (Perisco et. al., 2013).
Using Whole-Exome Sequencing (WES) to 
determine possible genetic links to ASD
Whole-Exome Sequencing (WES) is a technique which captures 
and sequences the exons in the genome to reveal all de novo 
and low frequenting alleles that contribute to genetic risk for dis-
ease.  This method is cheaper than Whole-Genome Sequencing, 
because instead of searching through the entire genome, it only 
goes through the exons in the genome, which only takes up 2-3% 
of the genome.  This technique is better than the previously used 
technique of Genome Wide Association Studies (GWAS) be-
cause GWAS only reveals risk factors that are common in the 
population (Icahn School of Medicine, 2012).  WES is particularly 
good for finding the cause of ASD because ASD can be caused 
from different genes in many different locations with a weak gen-
otype and phenotype correlation (Perisco et. al., 2013).
A study was done applying WES on families where the spouses 
were related and on families where cousins shared the same 
disease.  This way it is easier to identify specific mutations that 
cause ASD.  The mutations that were identified on the genes 
were hypomorphic mutations, meaning that the altered gene 
product has a reduced level of activity, which can explain the 
wide spectrum of ASD.  This analysis was done on three families. 
In this paper the first family will be discussed.
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The first family had three children with ASD and two unaffected 
children.  The parents were first cousins.  WES was performed 
and it showed a single linkage peak in a large homozygous in-
terval, and suggested a 900:1 likelihood that the responsible mu-
tation was found in this homozygous interval.  Then WES was 
performed on one of the affected children.  The linked interval 
showed only a single rare change that was absent in the known 
databases and population matched controls. 
This mutation was on a gene that is responsible for the produc-
tion of the enzyme AMT, aminomethyltransferase.  This enzyme 
is needed for the breakdown of glycine.  Sanger Validation con-
firmed that the mutation was heterozygous in both parents, ho-
mozygous in the affected children, and absent or heterozygous in 
the unaffected children. 
Mutations in AMT cause nonketotic hyperglycemia (NKH), which 
is a neonatal syndrome that causes lethargy, hypotonia, several 
seizures and death within the first year.  Rarer, atypical forms of 
NKH have been described in association with hypomorphic mis-
sense AMT mutations.  This manifests at a later age and causes 
delay in expressive language, behavioral problems and seizures. 
While individually non diagnostic, when all three children were 
tested they exhibited a range of neurological symptoms that 
were strongly suggestive of NKH (Yu et. al., 2013).
The amygdala theory of autism
There is a network of neural regions that comprise the “social 
brain”: the orbit-frontal cortex, the superior frontal sulcus, and 
the amygdala.  This region of the brain is responsible for social 
intelligence, a quality which ASD patients are known to be lack-
ing.  The Neuroscience and Behavioral Reviews has come up 
with The Amygdala Theory of Autism, where they hypothesize 
that patients with ASD have an amygdala deficit which causes 
the deficit in social skills.  
An experiment was done on rhesus monkeys which showed 
that ibotenic acid lesions of the amygdala affect the social be-
havior of the monkeys and they also became socially isolated. 
When the amygdala-lesioned monkeys were sent into the wild, 
they were unresponsive to group members, failed to display ap-
propriate social signals and they withdrew from other animals. 
When another study was done, where lesions were made to the 
monkeys’ anterior temporal lobe, which included the amygdala, 
the monkeys showed specific symptoms, for example they had a 
tendency to overreact to all objects, they were hyperemotional, 
they had a loss of fear, and they started to investigate objects 
with their mouth instead of their hands. 
Then a study conducted with humans was done.  They used 
single photon emission computed tomography that showed that 
patients with ASD show significant reductions in the temporal 
lobe blood flow.  The study was done in fuller depth where an 
fMRI (functional MRI) was done on adults with ASD that showed 
significantly less amygdala activation during a mentalizing task 
called “Judging the Mind in the Eye” task.  In this experiment, six 
people with autism were matched for mean age, handedness, IQ, 
socioeconomic status and educational level with twelve people 
in the normal group.  
In the fMRI scanner a blocked periodic ABA design was used. 
There were two tasks.  The first task, Task A, was supposed to 
induce periodic MR signal changes, with signal maximum in brain 
regions relatively specialized from gender recognition from fa-
cial stimuli.  In this task, the subjects were visually presented 
with pictures of eyes and were asked to indicate by right button 
pressing if the picture was a male or female.  
The second task, Task B, was checking the periodic MR signal 
change with signal maximum in brain regions relatively special-
ized in mental state recognition from facial stimuli.  In this task, a 
response involved choosing between two words that described 
the mental state of the photographed person.
The key difference between the two tasks was seeing the sub-
ject’s judgement between the two pictures.  Social intelligence is 
about picking up social cues, such as the expression of people’s 
faces to understand what the person is thinking.
The subjects who had ASD had a hard time doing task B.  The 
fMRI data was analyzed in two stages.  First, generic brain ac-
tivation maps were constructed separately for the control 
and autistic groups.  By doing so, they were able to determine 
which voxels were activated in each group by each of the two 
tasks.  Secondly, ANOVA was used to determine the voxels that 
demonstrated a significant difference between groups in mean 
power of response to each task.
The autistic group activated the frontal components less ex-
tensively than the control group, and they did not activate the 
amygdala at all.  The control group demonstrated significantly 
greater power of response in their bilateral superior temporal 
gyrus.  The autistic group seems not to use the amygdala for the 
task, and compensated by using a greater processing load on 
temporal lobe structures, which specializes in verbally labeling 
complex visual stimuli.  This may be because of compensation 
for an amygdala abnormality (Baron-Cohen et. al., 2000).
Maternal diabetes and autism
A study was done to investigate if Gestational Diabetes Mellitus 
(GDM) in the mother may result in the child having ASD. 
Specifically, researchers were determining if the timing of when 
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the mother developed GDM had any significance whether the 
child would develop ASD.  
This study included children who were born at 28-44 weeks 
gestation.  Women who had type 1 diabetes and congenital 
anomalies were excluded from the study.  The primary variable 
was maternal type 2 diabetes or maternal GDM during preg-
nancy.  Exposures were broken up into three categories- 1. No 
exposure to maternal diabetes, 2. Exposure to maternal type 2 
diabetes, and 3. Exposure to maternal GDM.  Other variables 
that were included were maternal age at delivery, education, 
self-reported maternal race/ethnicity, and the gender of the 
child.  For the GDM exposed group, the different methods that 
were used to diagnose were also recorded.  The gestational 
weeks were also split up into three categories- 1. Diagnosed 
26 weeks or earlier, 2. Diagnosed after 26 weeks but before 30 
weeks, 3. Diagnosed at 30 weeks or later.  
The primary data analysis was collected from 322,323 chil-
dren.  The children were checked up on approximately five 
and a half years after birth.  During this time, 3,388 children 
were diagnosed with ASD.  A large amount of mothers who 
got GDM during the first 26 weeks of pregnancy gave birth 
to a child with ASD.  It is also interesting to note that among 
the children who had ASD, 121 of them had older siblings who 
also had ASD.
To summarize, mothers with pre-existing type 2 diabetes were 
not significantly associated with risk of ASD, but mothers who 
got GDM earlier than 26 weeks of pregnancy were significantly 
associated with risk of ASD (Xiang et. al., 2015).
De Novo Mutations
De novo mutation is an alteration of a gene that was present for 
the first time in one family member as a result of a mutation in a 
germ cell (egg or sperm) of one of the parents or in the fertilized 
egg itself (Genetics Home Reference, 2015).  De novo mutations 
are important in finding the cause of ASD.  
Studies show that the majority of de novo mutations do not 
cause the disease, they only increase the risk of getting the dis-
ease.  There may be several genes in which a high risk of de novo 
mutations can occur from.  Through these studies many de novo 
mutations were found that predicted that these mutations would 
disrupt the gene function in a child with ASD, however these mu-
tation are not necessarily what causes the disease.  Two studies 
also found that de novo mutations are caused from the paternal 
side and are age dependent.  There is a detectable increase in au-
tism risk with children who were born to older fathers (Perisco 
et. al., 2013). 
Advancing parental age and autism
There are a number of studies which are trying to determine if 
the age at which the parents conceived the child increases the 
risk of the child being born with ASD.  Whole-Exome Sequencing 
links older fathers to de novo mutations and increased risk of 
having a child with ASD.  The linkage of older mothers having a 
child with ASD follows different pathways.
Prevalence of ASD has increased from 5 cases per 10,000 peo-
ple in the 1980’s to the latest CDC’s estimate of 1 case in every 
68 people.  This may be due to a variety of reasons, including 
changes in diagnostic practice, heightened awareness, or even 
an actual increase in the disorder.  One factor that might cause 
ASD is parental age, since there is a tendency in recent years for 
people to become parents later in life.  In Spain and England the 
proportion of mothers who had children after 35 years old in 
1980 was 14% and 25% respectively.  In 2007, the proportion of 
mothers who had children after 35 years old increased to 25% 
and 40% respectively.  
There are more than forty studies being done trying to link age 
of parents when they had kids to ASD.  While individual studies 
are not consistent with their findings, this can be because of a 
number of factors.  The discrepancies can be caused by incon-
sistent sample sizes and characteristics, or missing data.  The 
studies did conclude an increased risk of ASD from both older 
parents, an older father but not older mother, and older mother 
but not older father, and neither an old mother or old father. 
Inconsistencies could have also been affected by the fact that 
these studies did not take into account socioeconomic status 
of the families or co-parental age.
The general consensus is that advancing paternal age (APA) and 
advancing maternal age (AMA) are independent factors that can 
increase the risk of having children with ASD.
In 2012 meta-analysis focused on advancing maternal age and a 
link to autism, using data from over 25,000 ASD patients, and 
eight million controls aggregated from 10 studies.  The results 
were that mothers who were 35 years or older when they had 
the child had a 1.5 fold increased likelihood of having a child with 
ASD compared to mothers who had children at 25-29 years of 
age.  In 2010, a study was done to test the theory of advancing 
paternal age and its link to autism.  Meta-analysis was done on 
eleven studies and found that fathers who were 40-49 years old 
when they had children, had a 1.8 fold increased likelihood of 
having a child with ASD, compared to fathers who were 29 years 
old or younger.
APA effects on ASD
At this point the question is how APA and AMA are associated 
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with a child being born with ASD.  One possibility of why age 
affects ASD is age- related mutagenesis in the male germ cell. 
While a female germ cell undergoes 22 mitotic cell divisions in 
utero, male germ cells undergo 30 mitotic cell divisions in em-
bryogenesis, and then divide every 16 days from puberty and on. 
Because the male germ cell undergoes many more cell divisions 
during his reproductive age, there is more of a possibility of gene 
copying errors, which can lead to de novo mutations in the male’s 
child, which can cause ASD.
Multiple studies that are using Whole-Exome or Genome 
Sequencing found that higher numbers of de novo loss-of-
function single nucleotide variants are seen in fathers of in-
creasing age.  While it is fine for a new born to have between 
30-100 de novo point mutations, there is an increase of about 
one to two mutations for each increasing year of a father’s 
age.  If the mother is also older, it increases the likelihood of 
more de novo mutations, because AMA and APA can be linked 
together.
Two studies were conducted to disentangle APA effects from 
AMA effects on the child.  The studies used multiple regression 
which was adjusted so that both parental ages were entered 
as predicators.  It was found that APA remained a significant 
predicator in de novo mutations while AMA effects were neg-
ligible.  Two thousand, five hundred families who had one child 
with ASD were analyzed and found that a majority of the de 
novo mutations originated from the father.  It should be point-
ed out that although de novo mutations can affect any biolog-
ical system, there is reason to believe that de novo mutations 
differentially impact brain development because the brain may 
have fewer redundancy mechanisms that are needed to inhibit 
mutations (Lee et. al., 2015).
They hypothesized that if mutations in germ cells result in a 
slightly faster rate of cell division, then cells with these mu-
tations will expand within the testes and logically they will 
contribute to the larger proportion of sperm.  This process is 
known as “selfish spermatogonial selection”.  This mechanism 
can favor the propagation of germ cells which are carrying mu-
tations that prefer to impact certain cellular signal pathways. 
(Lee et. al., 2015).
AMA effects on ASD
One possible correlation between AMA and ASD would be 
assisted reproductive technologies which are used by couples 
more commonly with increasing age.  A Swedish study was 
done which involved 2.5 million infants.  The results were that 
in vitro fertilization procedures had no association with risk 
of ASD, while a specific procedure called “Intracytoplasmic 
Sperm Injection (ICSI)” has a slightly increased risk of having 
children with ASD.  ICSI is done when there is paternal infer-
tility.  The reason why ICSI can increase risk of ASD is because 
the injection process can damage the egg which can increase 
the risk of adverse outcomes.
Another possible correlation can be the fact that a person 
accumulates more and more environmental toxins with in-
creasing age.  Environmental factors such as pesticides, heavy 
metal, and organic pollutions have been linked with increased 
risk of ASD.  Human brain samples were examined and found 
that exposure to polychlorinated biphenyl 95 strongly predict-
ed maternal 15q11-q13 duplication, which is one of the most 
common CNV findings in ASD cases (Lee et. al., 2015).
Other factors that effect advancing parental age 
and autism
A study was done using 1,251 ASD cases occurring in over 
250,000 births throughout the United States.  This study found 
a connection between parental age and birth order with in-
creasing risk of ASD.  Younger parents (mother younger than 
35, father younger than 40), on their first birth, had a 1.7 fold 
increased odds of having a child with ASD compared to other 
young parents on their third birth and later.  Regardless of the 
age of the parents, the risk of ASD is increased in first born 
children.  Older parents (mother older than 35, father older 
than 40) on their third child or later had a 1.8 fold increase 
on the likelihood of having a child with ASD.  Older parents on 
their first child had a 3.1 fold increase on the odds of having a 
child with ASD.  To conclude, the effect of parental age on ASD 
is amplified if it is their first birth (Lee et. al., 2015).
Environmental chemical exposures and autism 
spectrum disorder
Autism can be caused by a mixture of genetic and environ-
mental influences, and studies are being done to understand 
the interplay of both contributions.  These contributions can 
be different from one person to the next.  A study in Sweden 
was done which included 14,000 children with autism.  The 
study showed that heritability contributed to 50% of a possi-
ble cause of autism while environmental factors contributed 
an equally strong role.  Genetic and environmental factors may 
work together to disrupt the normal process of nervous sys-
tem development, interfering with neuron formation and mi-
gration, synapse formation, or neurological connectivity which 
can cause ASD.
In this study, the chemical exposures that were included are 
ones that can be reduced in exposure, which opens up possibil-
ity for prevention of autism.  Of course it can only be reduced 
because not all exposure can be controlled, such as air pollution 
and any toxic chemical that are unknown to the patients. 
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Maternal smoking in pregnancy and ASD 
diagnosis
Seven studies were included which were done in the United 
States, Canada, Sweden, Norway, Finland, and England/Whales. 
These studies showed no association between maternal smok-
ing during pregnancy and ASD diagnosis.  Some of the studies 
focused on the spectrum of autism.  There was an elevation in 
two of the studies between maternal smoking during pregnan-
cy and higher functioning autism, such as Asperger’s syndrome, 
compared to lower functioning autism.  Overall, there is no 
conclusive evidence that maternal smoking or tobacco expo-
sure to a fetus has any effect on a child being born with autism 
(Kalkbrenner et. al., 2014).
Regulated and traffic related air pollutants 
exposure and ASD
Air pollutants include hundreds of chemicals which can be 
categorized into three categories: 1. Point pollutants arising 
from spatially separated large buildings, for example factories 
and power plants. 2. Area pollutants associated with popu-
lation density, for example gas stations and dry cleaners. 3. 
Mobile pollutants associated with vehicles.  In this paper we 
will be discussing the third category.  When these pollutants 
enter the atmosphere they undergo reactions that create new 
pollutants.  Specific chemicals that arise from traffic that will 
be discussed here are particulate matter (PM), NO2; nitrogen 
dioxide, and O3; ozone.  
Air pollutants enter the body through inhalation and direct 
transportation from the nose to the brain via the olfactory 
bulb.  Some chemical pollutants are known to induce oxida-
tive stress and cause a systemic inflammatory reaction, which 
can alter normal neurodevelopment.  Fetuses itself can come 
in contact with chemicals from air pollutants or they can be 
exposed to them from the elevated levels of inflammatory cy-
tokines in the maternal circulation.  
Seven studies were done in the United States with adequate 
sample sizes ranging from 284 to 7,594 children with autism. 
The studies also had controls under consideration such as ma-
ternal age and the parent’s level of education.  Season of birth 
is also important to take under consideration because occur-
rence of autism varies by season of conception for unknown 
reasons.  It is also important because certain air pollutants 
have a stronger concentration in some seasons over other 
season, such as influenza infection and vitamin D levels.
Results for this study concluded that exposure to pollutants 
such as PM2.5, PM10, and NO2, were associated with the risk 
of getting autism.  For almost every pollutant in every study, as-
sociations were stronger for exposures in the third trimester 
of pregnancy and the first year of life compared to earlier 
on in the pregnancy.  All of these studies estimated exposure 
to outside levels of these air pollutants using historical data 
that could be related geographically to the home residence 
of the pregnant woman or infant, because retroactive direct 
person-based air sampling was not possible (Kalkbrenner et 
al 2014).
Metal (Ethylmercury) from vaccinations  
and ASD
Connecting this discussion back to vaccinations, thimerosal 
was thought to be a toxic compound that increased the risk 
of autism.  Thimerosal is a vaccine preservative that contains 
ethylmercury which is considered a less toxic form of mercury 
compared to methylmercury. 
 Although the Institute of Medicine already stated that there 
is no concrete evidence that the MMR vaccine causes autism, 
people are still skeptical.  No one suspected thimerosal to be 
toxic, seeing as it was found in such small doses in vaccines. 
In the 1970’s it was known that large doses of mercury were 
harmful.  It was only in the late 1990’s that scientists suggested 
that even relatively low exposure to organic mercury could be 
dangerous to fetuses and young infants (Baker, 2008).  The U.S. 
Food and Drug Administration suggested removing thimerosal 
from vaccines in 2001, because of the biological plausibility that 
thimerosal may pose as a neurotoxic harm.  However, trace 
amounts of thimerosal are present in influenza vaccines which 
infants and pregnant women may be exposed to.  Six studies 
were included, testing for a link between thimerosal-containing 
vaccines and autism.  The results of the studies suggested that 
there is no connection between thimerosal and increased risk 
of autism (Kalkbrenner et. al., 2014).
Conclusion
The causes of autism are still vague.  Because it is characterized 
as a spectrum disorder there can be many different variables 
that can play a role in causing different levels of it.  The theo-
ry that vaccinations cause autism has become a popular idea, 
therefore much research has been done to make a correct con-
clusion.  Until the causes of autism are confirmed research is 
still being done to see what role vaccinations have on autism, 
however the research that has been done until now has con-
cluded that vaccinations do not have a link to ASD.  Another 
highly researched cause of autism is a genetic cause, be it a 
genetic mutation or a number of other different genetic vari-
ables.  In this paper the idea that different genetic mutations 
that can cause autism has been discussed, and while some stud-
ies have brought optimistic results, further studies have to be 
conducted.  Other genetic factors that have been discussed are 
the effect of maternal diabetes on the fetus, and parental age 
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when the child was conceived.  While further research is need-
ed to confirm these factors, the studies that have been done 
have given additional insight into what causes autism.  Another 
possible cause for ASD that was discussed was a mixture of 
genetic and environmental factors that the child was exposed 
to either as a fetus or as an infant.  While some environmental 
factors that have been tested had no correlation to ASD, other 
environmental factors did show a correlation, although more 
research is required.  
Many studies are constantly being done, and researchers are 
discovering more factors that might be a cause for ASD.  The 
closer they come to finding a cause, the closer they get to trying 
to find a way to prevent autism from becoming more prevalent, 
and maybe even closer to finding a possible cure for Autism 
Spectrum Disorder.
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